HTML Microdata document

This HTML5 document contains 42 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
n5	http://linked.opendata.cz/resource/mesh/concept/
rdfs	http://www.w3.org/2000/01/rdf-schema#
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n4	http://linked.opendata.cz/ontology/mesh/
owl	http://www.w3.org/2002/07/owl#
nci	http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#
xsdh	http://www.w3.org/2001/XMLSchema#

Statements

Subject Item: nci:C9702
rdf:type: owl:Class
rdfs:label: CHOPE Regimen
rdfs:subClassOf: _:vb662828 _:vb662829 nci:C63442 _:vb662824 _:vb662825 _:vb662826 _:vb662827
nci:P106: Therapeutic or Preventive Procedure
nci:P108: CHOPE Regimen
nci:P207: C0212922
nci:P325: <n0:ComplexDefinition xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:def-definition>An abbreviation for a chemotherapy combination that is used to treat non-Hodgkin lymphoma. It includes the drugs cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), vincristine sulfate (Oncovin), prednisone, and etoposide phosphate.</n0:def-definition><n0:def-source>NCI-GLOSS</n0:def-source></n0:ComplexDefinition>
nci:P366: Cyclophosphamide_Doxorubicin_Etoposide_Prednisone_Vincristine
nci:P90: <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>CHOPE</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI-GLOSS</n0:term-source><n0:source-code>CDR0000635776</n0:source-code></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone-Etoposide Regimen</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>CHOPE regimen</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI-GLOSS</n0:term-source><n0:source-code>CDR0000635778</n0:source-code></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>CHOPE</n0:term-name><n0:term-group>AB</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>VAC0P</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>CHOPE Regimen</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>
nci:P97: <n0:ComplexDefinition xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:def-definition>A regimen consisting of cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide used to treat both indolent and aggressive forms of non-Hodgkin's lymphoma.</n0:def-definition><n0:def-source>NCI</n0:def-source></n0:ComplexDefinition>
nci:code: C9702
n4:hasConcept: n5:M0212657

Subject Item: _:vb662824
rdf:type: owl:Restriction
owl:onProperty: nci:R123
owl:someValuesFrom: nci:C491

Subject Item: _:vb662825
rdf:type: owl:Restriction
owl:onProperty: nci:R123
owl:someValuesFrom: nci:C933

Subject Item: _:vb662826
rdf:type: owl:Restriction
owl:onProperty: nci:R123
owl:someValuesFrom: nci:C770

Subject Item: _:vb662827
rdf:type: owl:Restriction
owl:onProperty: nci:R172
owl:someValuesFrom: nci:C3211

Subject Item: _:vb662828
rdf:type: owl:Restriction
owl:onProperty: nci:R123
owl:someValuesFrom: nci:C456

Subject Item: _:vb662829
rdf:type: owl:Restriction
owl:onProperty: nci:R123
owl:someValuesFrom: nci:C405